Source: International Congress 2018 – New developments in the treatment of asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Diakova (Moscow, Russian Federation), Y. Mizernitskyi (Moscow, Russian Federation), L. Sokolova (Moscow, Russian Federation), E. Sorokina (Moscow, Russian Federation), I. Zorina (Moscow, Russian Federation). Long-term results of anti-IgE-therapy in severe uncontrolled child asthma.. 1037

Member's Comments

No comment yet.

Related content which might interest you: Factors resulting in uncontrolled severe persistent asthma in children Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004 Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Respiratory rehabilitation in children with severe asthma. Preliminary results Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 The profile of poor ICS adherence in uncontrolled moderate to severe asthma. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Is severe infantile bronchiolitis associated with severe childhood asthma? A whole population linkage study Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Long-term efficacy of QMF149 in persistent asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Interferon-α (IFN-α)-treatment of uncontrolled severe persistent asthma. Results from a 12-month open label study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Uncontrolled asthma has a higher disease burden compared to controlled asthma in adult onset but not in childhood onset asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020